The February 4th issue of JNCI features articles on two different treatments for advanced cancer of the larynx or hypotharynx; optimal strategies for cervical cancer screening; and a gene mutation that may be associated with both goiter and thyroid. Also in the Journal are articles on the radiation risks of mammography in women with BRCA mutations; human papillomavirus type 18 in precancerous lesions of the cervix; the role of the protein, STAT-3, in the anti-tumor effects of a compound found in cruciferous vegetables; and a gene mutation associated with resistence to the drug imatinib.
